Your browser doesn't support javascript.
loading
Brief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects.
Kalinowski, Leanna; Connor, Carly; Somanesan, Rathini; Carias, Emily; Richer, Kaleigh; Smith, Lauren; Martin, Connor; Mackintosh, Macauley; Popoola, Daniel; Hadjiargyrou, Michael; Komatsu, David E; Thanos, Panayotis K.
Afiliación
  • Kalinowski L; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
  • Connor C; Department of Psychology, University at Buffalo, Buffalo, NY, USA.
  • Somanesan R; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
  • Carias E; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
  • Richer K; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
  • Smith L; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
  • Martin C; Department of Psychology, University at Buffalo, Buffalo, NY, USA.
  • Mackintosh M; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
  • Popoola D; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
  • Hadjiargyrou M; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
  • Komatsu DE; Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biosciences, Behavioral Neuropharmacology and Neuroimaging Laboratory on Addictions, Research Institute on Addictions, University at Buffalo, Buffalo, NY, USA.
  • Thanos PK; Department of Life Sciences, New York Institute of Technology, Old Westbury, NY, USA.
Dev Psychobiol ; 62(2): 170-180, 2020 03.
Article en En | MEDLINE | ID: mdl-31456229
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Conducta Animal / Peso Corporal / Ingestión de Alimentos / Estimulantes del Sistema Nervioso Central / Locomoción / Metilfenidato Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Dev Psychobiol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Conducta Animal / Peso Corporal / Ingestión de Alimentos / Estimulantes del Sistema Nervioso Central / Locomoción / Metilfenidato Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Dev Psychobiol Año: 2020 Tipo del documento: Article País de afiliación: Estados Unidos